MPM Oncology Innovations Fund, 10% Owner: Aktis Oncology AKTS Buy · Filed 01/14

Trade details

Type: Insider buy
Amount: $20,029,986
Shares · price: 1,112,777 sh · $18.00 a share
Held after: 10,260,064 sh
Stock: Aktis Oncology AKTS
Person: MPM Oncology Innovations Fund10% Owner
Trade date: 26/01/12
Filed: 26/01/14
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 17 insiders
Holding change: +12.2%

Aktis Oncology trades, last 26 weeks

What else happened in Aktis Oncology around then

Filed or reported within 30 days of the trade day · 25/12/13~02/11

MPM Oncology Innovations Fund's recent trades

MPM Oncology Innovations FundShareholder
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$7,214
21,194 sh
$7,214
Filed 07/06
Traded 07/06
MPM Oncology Innovations FundShareholder
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$7,509
23,248 sh
$7,509
Filed 06/29
Traded 06/29
MPM Oncology Innovations FundShareholder
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$26.2K
53,425 sh
$26.2K
Filed 05/28
Traded 05/28
MPM Oncology Innovations FundShareholder
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$32.7K
63,540 sh
$32.7K
Filed 05/18
Traded 05/18
MPM Oncology Innovations FundShareholder
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$12.6K
18,485 sh
$12.6K
Filed 05/11
Traded 05/11